Wang HY, Dou KF, Yin D, Xu B, et al. Risk/Benefit Tradeoff of Prolonging Dual Antiplatelet Therapy More Than 12 Months in TWILIGHT-Like High-Risk Patients After Complex Percutaneous Coronary Intervention. Am J Cardiol 2020 Jul 24. pii: S0002-9149(20)30767.
PMID: 32811654